These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease. Cooper CB; Davidson AC; Cameron IR Bull Eur Physiopathol Respir; 1987; 23(1):15-22. PubMed ID: 3297214 [TBL] [Abstract][Full Text] [Related]
23. Criteria for use of theophylline (aminophylline) in inpatients and outpatients with pulmonary disease. Phillips MS Clin Pharm; 1992 Dec; 11(12):1033-8. PubMed ID: 1286554 [No Abstract] [Full Text] [Related]
24. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)]. Wiessmann KJ Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724 [TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of zaditen in the treatment of mastocytosis in children]. Kasimov N Vestn Dermatol Venerol; 1985 Oct; (10):52-4. PubMed ID: 3909688 [No Abstract] [Full Text] [Related]
27. [Ketotifen (Zaditen) and disodium cromoglycinic acid (Intal) in the therapy of bronchial asthma]. Nowak D; Magnussen H Prax Klin Pneumol; 1987 Sep; 41(9):319-23. PubMed ID: 3124092 [No Abstract] [Full Text] [Related]
28. [Zaditen (ketotifen) in the treatment of hay fever and vasomotor rhinitis]. Zawisza E; Blinowski J Otolaryngol Pol; 1985; 39(5):396-9. PubMed ID: 3912701 [No Abstract] [Full Text] [Related]
29. Phyllocontin in chronic airflow obstruction. Dunn A; Hoffman N; Wilson RS Br J Clin Pract; 1984 Feb; 38(2):63-5. PubMed ID: 6367798 [No Abstract] [Full Text] [Related]
30. [Personal experience with Zaditen in the prevention of respiratory diseases in children]. Bacinský M Bratisl Lek Listy; 1988 Feb; 89(2):106-12. PubMed ID: 3359344 [No Abstract] [Full Text] [Related]
31. [Sodium cromoglycate in the treatment of food hypersensitivity in children under 3 years of age]. Zur E; Kaczmarski M Pol Merkur Lekarski; 2001 Sep; 11(63):228-32. PubMed ID: 11761817 [TBL] [Abstract][Full Text] [Related]
32. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs]. Cipri A; Pozzar F; Dini FL Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668 [TBL] [Abstract][Full Text] [Related]
33. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease. Dasta J; Mirtallo JM; Altman M Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214 [No Abstract] [Full Text] [Related]
34. [Clinical effectiveness and prospects for using zaditen (ketotifen) in the therapy of allergic dermatoses]. Sergeev IuV; Potekaev NS Vestn Dermatol Venerol; 1987; (4):52-5. PubMed ID: 3604448 [No Abstract] [Full Text] [Related]
35. Aminophylline and its influence on ventilatory endurance in humans. Belman MJ; Sieck GC; Mazar A Am Rev Respir Dis; 1985 Feb; 131(2):226-9. PubMed ID: 3970454 [TBL] [Abstract][Full Text] [Related]
36. Some aspects of the management of bronchial asthma and chronic obstructive lung disease. Rowe WS Med J Aust; 1975 May; 1(20):623-5. PubMed ID: 238095 [No Abstract] [Full Text] [Related]
37. New concepts in bronchodilator therapy. Owens GR Am Fam Physician; 1986 Jan; 33(1):218-29. PubMed ID: 2934965 [No Abstract] [Full Text] [Related]